Aminolevulinic Acid
Showing 1 - 25 of 8,045
Refractory Mycosis Fungoides Trial in Scottsdale (drug, other, radiation)
Completed
- Refractory Mycosis Fungoides
- Aminolevulinic Acid Hydrochloride
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 3, 2023
5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for
Not yet recruiting
- High Grade Glioma
- +10 more
- 5-Aminolevulinic Acid (5-ALA) Gliolan®
- Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 28, 2023
Skin Tumors Trial in San Diego (aminolevulinic acid HCl gel, 10%, aminolevulinic acid HCl topical solution, 20%)
Not yet recruiting
- Skin Neoplasms
- aminolevulinic acid hydrochloride gel, 10%
- aminolevulinic acid HCl topical solution, 20%
-
San Diego, CaliforniaCosmetic Laser Dermatology/West Dermatology Research Center
May 3, 2022
High Grade Glioma Trial in Lake Success (5 Aminolevulinic Acid, CV01-delivered ultrasound)
Recruiting
- High Grade Glioma
- 5 Aminolevulinic Acid
- CV01-delivered ultrasound
-
Saint Louis, Missouri
- +2 more
Dec 21, 2022
Crohn Disease Trial in Lorenskog (5-aminolevulinic acid, Blue light photopheresis, Transfusion)
Recruiting
- Crohn Disease
- 5-aminolevulinic acid
- +4 more
-
Lorenskog, Akershus, NorwayAkershus University Hospital
Mar 8, 2022
Glioblastoma Trial in Münster (Gliolan, Radiodynamic therapy)
Recruiting
- Glioblastoma
- Gliolan
- Radiodynamic therapy
-
Münster, GermanyUniversity Hospital Münster, Klinik für Neurochirurgie
Nov 16, 2022
Gliomas, Malignant, Metastases to Brain Trial in Moscow (Ultrasound guided brain tumor resection, 5-aminolevulinic acid
Not yet recruiting
- Gliomas, Malignant
- Metastases to Brain
- Ultrasound guided brain tumor resection
- 5-aminolevulinic acid fluorescence-guided brain tumor resection
-
Moscow, Russian FederationSklifosovsky Institute of Emergency Care
Jul 26, 2022
5-Aminolevulinic Acid to Assess Bone and Tissue Profusion in
Recruiting
- Trauma
- +2 more
- Imaging using 5-Aminolevulinic Acid (5-ALA) during surgery
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Jan 26, 2022
Glioblastoma Multiforme, Adult Trial in Germany (Stereotactic biopsy followed by stereotactical photodynamic therapy with
Recruiting
- Glioblastoma Multiforme, Adult
- Stereotactic biopsy followed by stereotactical photodynamic therapy with 5-aminolevulinic acid
- Stereotactic biopsy
-
Dresden, Germany
- +4 more
Feb 15, 2022
Glioblastoma Multiforme Trial (5-Aminolevulinic Acid)
Not yet recruiting
- Glioblastoma Multiforme
- 5-Aminolevulinic Acid
- (no location specified)
Jan 16, 2023
Advanced Solid Tumor Trial in Philadelphia (Low dose radiation and ALA)
Recruiting
- Advanced Solid Tumor
- Low dose radiation and ALA
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 18, 2022
Brain Tumor, Pediatric Trial in Germany (5-Aminolevulinic Acid Hydrochloride, Oral)
Recruiting
- Brain Tumor, Pediatric
- 5-Aminolevulinic Acid Hydrochloride, Oral
-
Augsburg, Germany
- +5 more
May 5, 2022
Glioblastoma, High-grade Glioma Trial in Groningen (Cetuximab-IRDye800)
Recruiting
- Glioblastoma
- High-grade Glioma
-
Groningen, NetherlandsUMCG
Jun 26, 2023
Rosacea, Papulopustular Rosacea Trial in Washington (drug, device, other)
Completed
- Rosacea
- Papulopustular Rosacea
- Aminolevulinic acid topical solution 20%
- +2 more
-
Washington, District of ColumbiaMedical Faculty Associates - George Washington University
Dec 1, 2022
Actinic Keratoses Trial in Chicago (ALA (5-aminolevulinic acid), Blue light therapy)
Active, not recruiting
- Actinic Keratoses
- ALA (5-aminolevulinic acid)
- Blue light therapy
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine, Department
Mar 2, 2022
Actinic Keratoses Trial in San Francisco (Aminolevulinic Acid Topical 20% Topical Solution, BLU-U blue light phototherapy
Completed
- Actinic Keratoses
- Aminolevulinic Acid Topical 20% Topical Solution
- BLU-U blue light phototherapy illuminator
-
San Francisco, CaliforniaUCSF Dermatology
Mar 7, 2022
Tumor, Skull Base Tumor Trial in New York (5-Aminolevulinic acid Hydrochloride)
Recruiting
- Neoplasm
- Skull Base Neoplasm
- 5-Aminolevulinic acid Hydrochloride
-
New York, New York
- +2 more
Oct 28, 2021
Brain and CNS Tumors Trial in Cleveland (aminolevulinic acid, Surgical Resection)
Completed
- Brain and Central Nervous System Tumors
- aminolevulinic acid
- Surgical Resection
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 13, 2021
Actinic Keratoses Trial in Cleveland (Topical Aminolevulinate, Photodynamic therapy (PDT), Red light illumination)
Recruiting
- Actinic Keratoses
- Topical Aminolevulinate
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jun 20, 2023
High Grade Glioma Trial in Phoenix (SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS))
Recruiting
- High Grade Glioma
- SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
- MR-Guided Focused Ultrasound device (MRgFUS)
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Dec 22, 2022
Actinic Keratosis Trial in Cleveland (Topical aminolevulinate (10% ALA gel), Red light illumination)
Not yet recruiting
- Actinic Keratosis
- Topical aminolevulinate (10% ALA gel)
- Red light illumination
-
Cleveland, OhioCleveland Clinic, Dermatology and Plastic Surgery Institute, Cas
Aug 31, 2023
Meningioma Trial in Austria, Germany, United States (Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI))
Active, not recruiting
- Meningioma
- Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI)
-
Phoenix, Arizona
- +16 more
Dec 27, 2022
Brain Tumors Trial in Lebanon (5-aminolevulinic acid)
Active, not recruiting
- Brain Tumors
- 5-aminolevulinic acid
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
May 3, 2022
Neurofibromatoses Trial in Milwaukee (Part 1 Levulan injection, Part 1 Levulan surface application, Part 1 Levulan surface
Completed
- Neurofibromatoses
- Part 1 Levulan injection
- +6 more
-
Milwaukee, WisconsinThe Medical College of Wisconsin
Jun 16, 2021